Quidel Corporation

Healthcare · Medical Devices

10.70$ +3.4% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Income Statement

Quidel Corporation (QDEL) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 631 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement QDEL
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	LTM
Revenue	49	53	74	38	51	115	169	103	117	133	148	108	126	152	175	202	476	809	375	177	510	637	1,002	613	784	867	846	665	744	743	711	637	727	708	693	614	700	724	620	631	2,674
Cost of Revenue	18	19	24	18	19	56	63	45	48	50	57	49	51	57	60	53	92	108	73	69	134	148	260	276	376	418	398	369	375	361	379	361	375	382	350	339	364	403	356	358	1,482
Gross Profit	32	34	50	21	32	59	106	58	70	82	91	59	76	95	115	149	384	701	302	108	375	489	742	338	408	449	449	297	369	381	332	276	352	326	343	275	336	320	264	273	1,193
Research & Development	8.8	7.5	7.9	7.6	7.5	11	13	13	13	13	14	12	12	15	16	21	21	25	23	23	24	26	26	34	66	64	62	62	62	59	59	56	56	47	53	46	42	46	45	49	181
Selling, General & Administrative	6.6	6.5	7.2	6.8	6.6	8.7	11	12	11	12	13	13	12	14	14	16	16	20	20	21	21	22	25	7.3	204	187	7.3	179	194	173	205	173	186	181	187	178	187	194	199	190	770
Total Operating Expenses	29	28	31	29	29	46	52	52	50	51	57	52	51	60	63	65	76	84	78	85	94	113	121	258	351	363	349	323	343	341	2,090	394	337	427	311	456	1,040	387	291	295	2,013
Operating Income	2.1	5.9	19	-11	-2.5	3.9	51	0.4	17	28	31	5.8	21	35	52	84	308	617	224	23	282	377	621	80	57	87	100	-27	26	40	-1,758	-118	15	-100	33	-181	-705	-66	-27	-22	-820
Interest Expense	3.0	3.1	2.8	2.8	2.8	9.2	7.9	6.8	4.8	4.8	4.6	4.5	3.2	2.6	2.8	3.5	1.8	1.6	2.4	1.6	1.3	1.4	0.2	10	30	33	32	29	29	46	32	48	50	45	42	46	46	43	51	55	195
Pre-Tax Income	-0.9	2.8	16	-14	-5.3	-5.3	39	-8.8	11	23	27	0.6	18	33	49	80	296	616	222	22	282	375	621	43	31	41	60	-64	-16	-9.2	-1,799	-163	-29	-141	-8.8	-230	-757	-112	-80	-81	-1,030
Income Tax Expense	-0.3	4.7	2.1	-2.0	0.2	-0.2	4.7	-5.8	0.0	-9.7	1.7	-0.7	1.3	1.9	8.6	13	64	145	44	2.6	66	84	141	24	12	11	11	-11	-2.8	-16	-93	-15	-8.9	38	3.9	26	-24	18	12	12	18
Net Income	-0.6	-2.0	14	-12	-5.5	-5.1	34	-3.1	11	32	25	1.3	16	31	40	68	232	470	178	19	216	291	480	19	19	30	49	-53	-13	7.0	-1,706	-148	-20	-178	-13	-255	-733	-131	-92	-93	-1,048
EBITDA	7.3	11	25	-5.1	3.7	17	70	9.6	30	35	46	20	37	50	64	96	310	629	238	34	294	391	636	99	164	195	216	95	144	152	-1,638	1.0	134	13	141	-76	-597	43	81	-27	-499

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings